Clinical Level of the Long Non-Coding RNA Taurine Upregulated Gene ۱ as a Predictive Biomarker in Neoplasms: A Systematic Review
محل انتشار: مجله تحقیق در پزشکی مولکولی، دوره: 14، شماره: 4
سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 20
فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_REMJ-14-4_002
تاریخ نمایه سازی: 22 آبان 1405
چکیده مقاله:
Background: Long non-coding RNAs (lncRNAs) are important regulators of cancer development and progression. Taurine upregulated gene ۱ (TUG۱) has been proposed as a prognostic biomarker in several malignancies, although its clinical significance remains inconsistent. This systematic review evaluated the available evidence on the association between TUG۱ expression and prognosis in patients with cancer.
Methods: A systematic literature search was conducted on the Web of Science, PubMed, Scopus, ProQuest, ERIC, and ScienceDirect for studies published between January ۲۰۱۴ and December ۲۰۲۳. Original studies investigating the relationship between TUG۱ expression and cancer prognosis were included. Data on study characteristics, cancer type, sample size, TUG۱ detection method, follow-up, survival outcomes, and principal findings were extracted independently by two reviewers and synthesized qualitatively. Methodological quality was assessed using the Newcastle–Ottawa Scale (NOS).
Results: Twenty studies were included. Most reported that elevated TUG۱ expression was associated with poor prognosis, including shorter overall survival, reduced disease-free survival, tumor progression, recurrence, metastasis, and chemoresistance. These findings were consistently observed in hepatocellular carcinoma, colorectal cancer, bladder cancer, renal cell carcinoma, esophageal squamous cell carcinoma, osteosarcoma, acute myeloid leukemia, and Philadelphia chromosome-negative acute lymphoblastic leukemia. In contrast, inconsistent results were reported for lung cancer and glioma, where higher TUG۱ expression was associated with improved survival or showed no significant prognostic value in some studies. Study quality ranged from moderate to high (NOS scores: ۶–۸).
Conclusion: Current evidence suggests that TUG۱ is a promising prognostic biomarker in several malignancies. However, its prognostic significance appears to be cancer-specific, highlighting the need for large prospective studies to confirm its clinical utility.
کلیدواژه ها:
نویسندگان
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :